Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA indisulam CTRPv2 pan-cancer AAC 0.036 0.3
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA shikonin GDSC1000 pan-cancer AAC 0.036 0.3
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA Vandetanib CCLE pan-cancer AAC 0.051 0.3
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.059 0.3
Download CSV